CONVENTUS FLOWER ORTHOPEDICS ANNOUNCES EXPANSION OF ITS FLEX-THREAD™ TECHNOLOGY PLATFORM WITH FDA CLEARANCE OF THE ULNA INTRAMEDULLARY NAIL SYSTEM

Horsham, PA, January 19, 2023: Conventus Flower Orthopedics, an innovation-driven medical technology company, announced they have received U.S. Food and Drug Administration (FDA) 510(k) clearance for the Flex-Thread™ Ulna Intramedullary (IM) Nail System. The Flex-Thread Ulna Nail marks a new application and portfolio expansion to the company’s Flex-Thread technology platform.

CONVENTUS FLOWER ORTHOPEDICS APPOINTS BRADLEY NIEMANN AS CHIEF EXECUTIVE OFFICER

HORSHAM, Pa., July 19, 2022 /PRNewswire/ — Conventus Flower Orthopedics, a privately held medical technology company that pioneered the Ready-for-Surgery™ single-use, sterile packaged foot and ankle solutions and launched the first-to-market flexible intramedullary distal fibula nail, today announced that Brad Niemann has been appointed as the Company’s Chief Executive Officer (CEO), effective immediately.   “The Board of Directors and… Continue reading CONVENTUS FLOWER ORTHOPEDICS APPOINTS BRADLEY NIEMANN AS CHIEF EXECUTIVE OFFICER